Sort
141,003 grants matching “cytokine”
Depression & CHD: Cellular-Molecular Mechanisms
$749,381Edward Carlos Suarez · Duke University · R01 · FY2010 · HL
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
$749,369Richard P Sloan · Columbia University Health Sciences · R01 · FY2021 · AG
ENaC regulation and its role in blood pressure homeostasis
$749,328Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$749,298Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE
Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome
$749,262Lindsey Colman McKernan · Vanderbilt University Medical Center · R01 · FY2025 · DK
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
$749,259John Koethe · Vanderbilt University Medical Center · R01 · FY2020 · DK
New Paradigms in Gene Regulation During Influenza Virus Infections
$749,229Curt M Horvath · Northwestern University · U01 · FY2010 · AI
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$749,221Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$749,200Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2019 · AG
Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging
$749,189Jennifer E Snyder-Cappione · Boston University Medical Campus · R01 · FY2022 · AG
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy
$749,187Alexander Marson · J. David Gladstone Institutes · R01 · FY2025 · CA
Fetal Antecedents to Depression and Risk for CVD
$749,182Jill M Goldstein · Brigham And Women'S Hospital · R01 · FY2009 · MH
A Platform Technology to Genetically Reprogram Cancer Cells for Enhanced Immunotherapy
$749,156Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2025 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$749,110Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines
$749,101George M Shaw · University Of Pennsylvania · R01 · FY2016 · AI
Natural Immunity Against Chlamydia trachomatis
$749,091Toni Darville · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
$749,079Richard P Sloan · Columbia University Health Sciences · R01 · FY2010 · HL
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$749,043Petros C Karakousis · Johns Hopkins University · R01 · FY2022 · AI
Therapy and Prophylaxis for Genital Tract Infection
$749,000Yingru Liu · Therapyx, Inc. · R44 · FY2014 · AI
Therapy and Prophylaxis for Genital Tract Infection
$749,000Yingru Liu · Therapyx, Inc. · R44 · FY2015 · AI
Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome
$748,953Christopher J Lessard · Oklahoma Medical Research Foundation · R01 · FY2020 · AR
Neuronal Latency and Toxoplasma
$748,925Christopher A Hunter · University Of Pennsylvania · R01 · FY2021 · AI
CSF, MRI, and PET biomarkers of neuroinflammation in Alzheimer's disease
$748,911William Tzu-Lung Hu · Emory University · R01 · FY2018 · AG
PET Detection of CCR2 in Human Atherosclerosis
$748,903Robert J Gropler · Washington University · R01 · FY2022 · HL
PET Detection of CCR2 in Human Atherosclerosis
$748,903Robert J Gropler · Washington University · R01 · FY2021 · HL